Pharmafile Logo
Pharmafocus logo
Advanced Search
Allergan image

Allergan and Valeant trade blows as shareholder meeting looms

November 6, 2014
Sales and Marketing Actavis, Allergan, Forest, Valeant, merger, warner

Allergan’s efforts to block a key supporter of Valeant’s hostile takeover bid from voting at next month’s special shareholder meeting …

News
Wearables image

Consumers want more from wearables market

November 6, 2014
Medical Communications, Sales and Marketing Apple, Microsoft, Samsung, mhealth, pwC, watch, werables

The interest in mobile health (mHealth) wearables is gaining traction, but consumers want more affordable devices that offer greater engagement …

News
Roche image

Roche unveils plans for first Asian diagnostics plant

November 6, 2014
Medical Communications, Sales and Marketing Asia-Pacific, China, Roche, asia pacific, asian, manufacturing

Roche has said it will invest 450 million Swiss francs ($468m) in the construction of a diagnostics manufacturing facility in …

News
terence_bradley_rock

ROCK medical communications appoints MD

November 6, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston, ROCK, terence bradley

ROCK medical communications has appointed Terence Bradley to be its managing director. Most recently Bradley was the founding director of …

Appointment
aileen_abpi

Former Vodaphone head to lead ABPI comms

November 5, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Aileen Thompson, meadon, vodaphone

The ABPI has appointed a new director of communications in Aileen Thompson, a former Vodaphone head who replaces Catherine Meadon in …

Appointment
Welsh Assembly image

Wales Assembly facing questions over cancer

November 5, 2014
Research and Development, Sales and Marketing CDF, Cancer, NHS, Wales, Welsh, assembly, drugs fund, oncology

The state of cancer services in Wales has come under increased scrutiny this week as the country’s ability to provide …

News
Iressa image

Retrospective study backs Iressa use in oesophageal cancer

November 5, 2014
Research and Development, Sales and Marketing AstraZeneca, Cancer, Cancer Oesophagus Gefitinib, Iressa, gefitinib, oncology

A group of oesophageal cancer patients can increase their survival by six months or more if treated with AstraZeneca’s Iressa, …

News
Covance image

LabCorp buys Covance for $6.1 billion

November 5, 2014
Research and Development, Sales and Marketing CRO, Covance, king, labcorp, medical

US medical diagnostics firm LabCorp has entered the drug development business via a $6.1 billion deal to buy contract research …

News
david_smoller_horizon

Horizon Discovery names executive director

November 5, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Horizon Discovery, david smoller

Cambridge-based genetics research firm Horizon Discovery has appointed Dr David Smoller to be an executive director on its board. Smoller …

Appointment
Astrazeneca image

AstraZeneca buys biotech Definiens

November 4, 2014
Research and Development, Sales and Marketing AstraZeneca, Janssen, MedImmune, Pharmacyclics, binnig, definiens

AstraZeneca has strengthened its oncology capabilities with the acquisition of Definiens, a German company that has pioneered cancer imaging and …

News

Astellas teams up with Proteostasis against protein defects

November 4, 2014
Research and Development, Sales and Marketing Astellas, Biogen IDEC, Protein, Proteostasis, upr

Astellas has announced it will collaborate with Proteostasis Therapeutics to develop drugs for diseases caused by protein defects, using the …

News
Rawlins image

Sir Michael Rawlins appointed chair of MHRA

November 4, 2014
Manufacturing and Production, Medical Communications, Sales and Marketing MHRA, NHS, NICE, gordon duff, michael rawlins

The Medicines and Healthcare Products Regulatory Agency (MHRA) has confirmed that former NICE head Sir Michael Rawlins is to serve …

News
GSK image

NICE backs GSK’s leukaemia drug Arzerra following price cut

November 4, 2014
Sales and Marketing Arzerra, CLL, GSK, NHS, NICE, leukaemia

NICE has recommended that GlaxoSmithKline’s Arzerra be prescribed under the NHS for patients with chronic lymphocytic leukaemia (CLL), after a …

News
Biogen image

EMA review for Biogen Idec’s haemophilia A therapy

November 4, 2014
Sales and Marketing Biogen, elocta, eloctate, haemophilia a, idec, sobi

The EMA is set to review Biogen Idec and Sobi’s haemophilia A therapy Elocta after validating the drug’s marketing authorisation …

News
garg_anylynam

Alnylam poaches VP from Bristol-Myers Squibb

November 4, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alnylam, pushkal garg

US-based RNAi therapeutics firm Alnylam Pharmaceuticals has appointed Dr Pushkal Garg to the position of senior vice president of its …

Appointment

AstraZeneca completes respiratory deal with Almirall

November 3, 2014
Research and Development, Sales and Marketing Almirall, AstraZeneca, Pfizer, deal, duaklir, merger, respiratory

AstraZeneca has finally completed its takeover of Almirall’s respiratory drug portfolio in a deal worth $875 million. As reported by …

News

Novo Nordisk to open $130 million diabetes labs

November 3, 2014
Manufacturing and Production, Sales and Marketing Denmark, Måløv, Novo Nordisk, Tresiba, Victoza, diabetes

Novo Nordisk has invested $130 million in new diabetes laboratories as the company looks to focus more strongly on the …

News

UK doctors are ignoring statin guidance

November 3, 2014
Sales and Marketing British Medical Association, GPs, NHS, NICE, Royal College of GPs, Royal College of Physicians, statins

A survey of UK doctors has found that many are refusing to apply NICE advice to offer statin therapy to …

News

Reprieve for Boehringer plant as Chinese buyer comes forward

November 3, 2014
Manufacturing and Production Boehringer, China, Petersburg, UniTao Pharmaceuticals

A US manufacturing facility cued up for closure by Boehringer Ingelheim has been bought by a Chinese drugmaker. Boehringer had …

News

Growing IPF drugs market evident at ERS Congress

November 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ERS, Esbriet, IPF, elf, european respiratory society, ofev

Arriving in Germany for this year’s European Respiratory Society (ERS) International Congress 2014, what awaited Pharmafile at the Ausgang was …

Feature
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026